APOC3 and hypertriglyceridemia: Early studies in APOC3 transgenic mice concluded that the hypertriglyceridemia in those mice is not due to increased hepatic TRL APOB production or decreased lipolysis by LPL but rather results primarily from decreased tissue uptake of TRLs from circulation (48).